APRIL STOWERS: Open Payments
NPI 1003202805 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$42,337 in 161 payments from 14 companies in 2025. Trend: 2023 $8,231 · 2024 $30,452 · 2025 $42,337
Speaker / faculty: $14,600Speaker / faculty: $13,881Travel & lodging: $10,100Food & beverage: $3,061Consulting: $695
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 69 | $22,282 |
| Lilly USA, LLC | 63 | $19,359 |
| Otsuka America Pharmaceutical, Inc. | 7 | $163 |
| Alexion Pharmaceuticals, Inc. | 3 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Janssen Biotech, Inc. | 3 | $67 |
| ARGENX US, INC. | 2 | $48 |
| EMD Serono, Inc. | 2 | $48 |
| UCB, Inc. | 2 | $47 |
| Genentech USA, Inc. | 2 | $44 |
Products named: Leqembi, KISUNLA, REXULTI, AMYVID, ULTOMIRIS, LEQVIO, Zilbrysq, Ocrevus Zunovo.
Industry payments across IL — which companies pay providers there.
